Association between mRNA expression of chemotherapy-related genes and clinicopathological features in colorectal cancer: A large-scale population analysis

por SHIMAMOTO, YUJI, NUKATSUKA, MAMORU, TAKECHI, TEIJI, FUKUSHIMA, MASAKAZU
Publicado 2016

Pharmacokinetic Modulation of Plasma 5‐Fluorouracil Concentrations to Potentiate the Antitumor Activity of Continuous Venous Infusion of 5‐Fluorouracil

por Fujii, Setsuro, Fukushima, Masakazu, Shimamoto, Yuji, Shirasaka, Tetsuhiko
Publicado 1989

Antitumor Activity of BOF‐A2, a New 5‐Fluorouracil Derivative

por Fujii, Setsuro, Fukushima, Masakazu, Shimamoto, Yuji, Ohshimo, Hideyuki, Imaoka, Takeshi, Shirasaka, Tetsuhiko
Publicado 1989

Effects of the Plasma Concentration of 5‐Fluorouracil and the Duration of Continuous Venous Infusion of 5‐Fluorouracil with an Inhibitor of 5‐Fluorouracil Degradation on Yoshida Sa...

por Fujii, Setsuro, Shimamoto, Yuji, Ohshimo, Hideyuki, Imaoka, Takeshi, Motoyama, Masaaki, Fukushima, Masakazu, Shirasaka, Tetsuhiko
Publicado 1989

Cellular and Biochemical Mechanisms of the Resistance of Human Cancer Cells to a New Anticancer Ribo‐nucleoside, TAS‐106

por Shimamoto, Yuji, Kazuno, Hiromi, Murakami, Yuko, Azuma, Atsushi, Koizumi, Katsuhisa, Matsuda, Akira, Sasaki, Takuma, Fukushima, Masakazu
Publicado 2002

Antitumor Activity and Pharmacokinetics of TAS‐106, l‐(3‐C‐Ethynyl‐β‐D‐ribo‐pentofuranosyl)cytosine

por Shimamoto, Yuji, Fujioka, Akio, Kazuno, Hiromi, Murakami, Yuko, Ohshimo, Hideyuki, Kato, Toshiyuki, Matsuda, Akira, Sasaki, Takuma, Fukushima, Masakazu
Publicado 2001

Sensitivity of Human Cancer Cells to the New Anticancer Ribo‐nucleoside TAS–106 Is Correlated with Expression of Uridine‐cytidine Kinase 2

por Shimamoto, Yuji, Koizumi, Katsuhisa, Okabe, Hiroyuki, Kazuno, Hiromi, Murakami, Yuko, Nakagawa, Fumio, Matsuda, Akira, Sasaki, Takuma, Fukushima, Masakazu
Publicado 2002